The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

MDC 25 years

Research Highlights

Inducing an identity crisis in liver cells may help diabetics

Francesca Spagnoli's team reprogrammed cells from the liver of mice to become precursor cells of the pancreas by altering a single gene. The results could help diabetics in the future.


Alessandro Prigione: modelling mitochondrial disease

Moving from mitochondrial research to stem cell biology gave Alessandro Prigione new tools and perspectives. Now he has made a model of mitochondrial disease from stem cells with promising results.


Further research highlights


Of bits, bytes, and bacteria: a week of systems biology at the MDC

Pupils participating in the MINT Excellence Academy in "Systems Biology" visited the MDC this week. Twenty pupils have catched a glimpse of how researchers combine laboratory and computational science.


Cardio specialist Suphansa Sawamiphak heads new junior research group at the MDC

2017's first new research group at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) has started its work: Dr. Suphansa Sawamiphak and her team investigate the role of macrophages in myocardial infarction.


Antibody against bone marrow tumor developed at MDC is put into application

Researchers at the MDC have developed antibodies that promise to heal multiple myeloma. The biotechnology company Heidelberg Pharma will now develop one of these antibodies to an antibody-toxin agent and test it clinically at the end of 2018.


Further news on MDC Insights